BeStock  

Stevanato Group STVN

$15.65 −$0.28 (-1.76%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $15.65 0.00%
Open$15.90
Prev close$15.93
Day range$15.35 – $16.15
Volume752.3K
Market cap$4.27B
P/E (TTM)28.0
Dividend yield0.39%

Fundamentals

Latest reported quarter: Q3, ended Sep 2026 · reported in EUR

Revenue€326.06M+7.6% YoY
Operating profit€60.33M+14.4% YoY
Net profit€41.84M+16.0% YoY
Diluted EPS€0.15+15.4% YoY
Free cash flow€21.38M+1,933.2% YoY
Operating cash flow€57.64M

Revenue, last 8 quarters

€330.6MDec '24€256.6MMar '25€280.0MJun '25€303.2MSep '25€346.5MDec '25€273.6MMar '26€302.0MJun '26€326.1MSep '26

Net profit, last 8 quarters

€48.3MDec '24€26.5MMar '25€29.7MJun '25€36.1MSep '25€47.6MDec '25€28.0MMar '26€23.0MJun '26€41.8MSep '26

Diluted EPS by quarter

0.18Dec '240.10Mar '250.11Jun '250.13Sep '250.17Dec '250.10Mar '260.08Jun '260.15Sep '26

Free cash flow by quarter

€22.3MJun '24€18.3MSep '24€-47.6MDec '24€28.1MMar '25€-15.4MJun '25€-1.2MSep '25€-485.0KDec '25€21.4MSep '26

Annual revenue

€662.0MFY20€843.9MFY21€983.7MFY22€1.1BFY23€1.1BFY24€1.2BFY25

Profitability & balance sheet

Gross margin29.2%
Operating margin17.7%
Net margin11.2%
Return on equity9.3%
Return on assets5.5%
Return on invested capital7.3%
Current ratio1.73
Liabilities / assets40.2%
Cash & investments€115.62M
Total debt€464.67M
Net cash (debt)-€349.05M

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Biopharmaceutical and Diagnostic Solutions€294.30M 85.7%
  • Engineering€49.21M 14.3%

This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.

Income statement

Line item 2026 Q3
(EUR)
2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
Total Revenue as Reported €326.06M €302.00M €273.60M €1.19B €346.48M
Total Operating Revenue €326.06M €302.00M €273.60M €1.19B €346.48M
Cost of Revenue €231.11M €215.19M €198.40M €842.41M €239.58M
Gross Profit €94.96M €86.81M €75.20M €343.88M €106.90M
Operating Expense €34.63M €35.53M €36.40M €145.08M €36.82M
Selling and Admin Expenses €31.55M €31.75M €32.00M €119.06M €32.51M
-Selling & Marketing Expense €8.09M €8.15M €6.70M €27.66M €7.96M
-General & Admin Expense €23.46M €23.61M €25.30M €91.40M €24.55M
Research & Development €6.14M €6.21M €5.80M €25.44M €5.81M
Other Operating Expenses -€3.06M -€2.44M -€1.40M -€8.24M -€3.47M
Operating Profit €60.33M €51.28M €38.80M €198.80M €70.08M
Net Non-Operating Interest Income (Expense) -€1.18M -€1.01M €500,000.00 -€5.77M -€1.46M
Non-Operating Interest Income €459,000.00 €338,000.00 €3.40M €1.03M €216,000.00
Non-Operating Interest Expense €1.39M €1.29M €2.90M €6.48M €1.60M
Total Other Finance Costs €251,000.00 €65,000.00 – €312,000.00 €78,000.00
Other Income (Expense) €413,000.00 -€12.15M – -€3.93M -€2.87M
Gain on Sale of Security €397,000.00 €79,000.00 – -€3.93M -€2.87M
Special Income (Charges) €16,000.00 -€12.23M – – –
-Gain on Sale Of Business €16,000.00 -€12.23M – – –
Pretax Profit €59.56M €38.12M €39.20M €189.11M €65.76M
Tax €17.72M €15.16M €11.20M €49.28M €18.21M
Net Profit €41.84M €22.96M €28.00M €139.83M €47.55M
Profit from Continuing Operations €41.84M €22.96M €28.00M €139.83M €47.55M
Minority Interests -€5,000.00 -€3,000.00 – -€8,000.00 -€3,000.00
Net Income to Parent Company €41.84M €22.96M €28.00M €139.84M €47.56M
Net Income to Common Stockholders €41.84M €22.96M €28.00M €139.84M €47.56M
Basic EPS €0.15 €0.08 €0.10 €0.51 €0.17
Diluted EPS €0.15 €0.08 €0.10 €0.51 €0.17
Dividend Per Share €0.00 €0.05 €0.00 €0.05 €0.00
Depreciation & Amortization & Depletion – – – €8.82M €2.18M
-Depreciation & Amortization – – – €8.82M €2.18M

Balance sheet

Line item 2026 Q3
(EUR)
2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
Total Assets €2.67B €2.62B – €2.54B €2.54B
Total Current Assets €959.00M €932.74M – €943.35M €943.35M
Cash and Cash Equivalents & Short-Term Investments €115.62M €83.58M – €130.60M €130.60M
-Cash and Cash Equivalents €114.90M €78.64M – €130.60M €130.60M
-Short Term Investments €716,000.00 €4.94M – – –
Receivables €540.70M €539.66M – €539.47M €539.47M
-Accounts Receivable €314.86M €300.29M €278.50M €302.69M €302.69M
-Accrued Interest Receivable €401,000.00 €219,000.00 – €248,000.00 €248,000.00
-Taxes Receivable €15.03M €18.96M €53.70M €32.55M €32.55M
-Other Receivables €210.41M €220.19M – €203.99M €203.99M
Inventory €301.55M €309.00M €294.40M €268.25M €268.25M
Total Non-Current Assets €1.71B €1.69B €1.67B €1.60B €1.60B
Net PPE €1.50B €1.49B – €1.40B €1.40B
-Gross PPE €2.19B €2.15B – €2.03B €2.03B
-Accumulated Depreciation -€681.78M -€660.05M – -€627.09M -€627.09M
Investments and Advances €1.22M €1.19M – €5.64M €5.64M
-Available for Sale Securities €1.10M €1.07M – €1.26M €1.26M
Financial Assets €1.23M €496,000.00 – €340,000.00 €340,000.00
Non Current Accounts Receivables €1.16M €1.16M – – –
Goodwill and Other Intangible Assets €91.66M €88.63M €86.50M €86.85M €86.85M
-Goodwill €49.93M €49.93M – €49.98M €49.98M
-Other Intangible Assets €41.73M €38.70M – €36.87M €36.87M
Non-Current Deferred Assets €108.86M €107.56M €110.20M €103.87M €103.87M
Other Non-Current Assets €1,000.00 – €1.47B – –
Total Liabilities €1.07B €1.07B – €1.06B €1.06B
Total Current Liabilities €554.54M €578.26M – €535.88M €535.88M
Payables €301.06M €303.28M – €343.53M €343.53M
-Accounts Payable €244.41M €255.93M €254.40M €263.31M €263.31M
-Total Tax Payable €56.66M €47.36M €121.20M €29.69M €29.69M
Short-Term Debt and Capital Lease Obligation €125.64M €123.95M – €121.75M €121.75M
-Current Debt €121.29M €119.61M – €117.36M €117.36M
-Current Capital Lease Obligation €4.35M €4.34M – €4.38M €4.38M
Current Provisions €3.20M €2.80M – €4.39M €4.39M
Current Deferred Liabilities €35.76M €44.47M – €56.97M €56.97M
Other Current Liabilities €88.88M €103.76M – €9.24M €9.24M
Total Non-Current Liabilities €519.16M €490.64M – €521.58M €521.58M
Long Term Debt and Capital Lease Obligation €343.38M €319.04M – €347.16M €347.16M
-Long Term Debt €336.79M €312.03M – €337.78M €337.78M
-Long Term Capital Lease Obligation €6.58M €7.01M – €9.38M €9.38M
Derivative Product Liabilities €0.00 €12,000.00 – €208,000.00 €208,000.00
Non-Current Liabilities €1.06M €1.06M – €3.16M €3.16M
Non-Current Deferred Liabilities €166.20M €159.66M – €112.11M €112.11M
Employee Benefits €8.31M €8.70M €6.80M €6.78M €6.78M
Other Non-Current Liabilities €217,000.00 €2.17M – €52.16M €52.16M
Total Equity €1.59B €1.55B €1.53B €1.49B €1.49B
Stockholders' Equity €1.59B €1.55B €1.53B €1.49B €1.49B
Capital Stock €22.23M €22.23M – €22.23M €22.23M
-Common Stock €22.23M €22.23M – €22.23M €22.23M
Additional Paid-In Capital €559.57M €559.57M – €559.57M €559.57M
Retained Earnings €1.07B €1.03B – €990.43M €990.43M
Less: Treasury Stock -€27.00M -€27.00M – -€27.08M -€27.08M
Gains/Losses Not Affecting Retained Earnings -€32.48M -€33.79M – -€58.66M -€58.66M
Other Equity Interests -€1,000.00 -€1,000.00 – -€1,000.00 -€1,000.00
Minority Interests €28,000.00 €33,000.00 – €38,000.00 €38,000.00
Prepaid Assets – – – €3.09M €3.09M
-Other Payable – – – €50.53M €50.53M

Cash flow

Line item 2026 Q3
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
2025 Q3
(EUR)
2025 Q2
(EUR)
Operating Cash Flow €57.64M €286.08M €94.11M €47.22M €44.91M
Net cash flow from continuing operations €57.64M €286.08M €94.11M €47.22M €44.91M
Net Income from Continuing Operations €59.56M €189.11M €65.76M €49.13M €39.11M
Gain/Loss from Continuing Operations -€100,000.00 -€510,000.00 -€91,000.00 -€19,000.00 -€79,000.00
Depreciation & Depletion & Amortization €25.59M €88.57M €24.59M €21.78M €21.57M
Other Non-Cash Items €412,000.00 €20.79M €8.09M €7.14M €5.61M
Change in Working Capital -€17.50M €50.63M €43.13M -€19.63M -€17.89M
-Change in Receivables -€11.48M €891,000.00 -€48.50M -€3.00M -€808,000.00
-Change in Inventory €19.27M -€41.46M €10.47M -€10.31M -€15.11M
-Change in Payables and Accrued Expense -€25.29M €91.19M €81.17M -€6.32M -€1.97M
Net cash flow from investing -€32.41M -€272.92M -€94.36M -€48.19M -€59.66M
Net Cash Flow from Continuing Investing Activities -€32.41M -€272.92M -€94.36M -€48.19M -€59.66M
Net PPE Purchase and Sale -€33.02M -€261.90M -€89.11M -€46.20M -€57.26M
Net Intangibles Purchase and Sale -€2.97M -€11.28M -€5.25M -€1.98M -€2.65M
Net Business Purchase and Sale €3.63M €0.00 €0.00 €0.00 –
Net Investment Purchase and Sale -€45,000.00 €251,000.00 €3,000.00 -€22,000.00 €252,000.00
Financing Cash Flow €10.30M €22.06M €17.19M €19.42M €21.21M
Net Cash Flow from Continuing Financing Activities €10.30M €22.06M €17.19M €19.42M €21.21M
Net Issuance Payments Of Debt €25.05M €36.80M €17.19M €34.16M €21.21M
Ending Cash Balance €114.90M €130.60M €130.60M €113.33M €94.17M
Net Change in Cash €35.53M €35.22M €16.94M €18.45M €6.46M
Beginning Cash Balance €78.64M €98.27M €113.33M €94.17M €90.72M
Effect of Exchange Rate Changes €734,000.00 -€2.89M €331,000.00 €713,000.00 -€3.00M
Free Cash Flow €21.38M €11.05M -€485,000.00 -€1.17M -€15.36M
Net Common Stock Issuance – €0.00 €0.00 – –
Cash Dividends Paid – -€14.74M €0.00 – –

Discussion

No comments yet — be the first to weigh in on STVN.

Sign in to join the discussion.

Scroll to Top